Page 47 - Pharma Sector

Sun Pharma rallies 9%, hits over 4-year high on strong June quarter results

The management said Sun Pharma witnessed a strong Q1, driven by a combination of robust core business growth, low base and some sale of Covid products

Windlas Biotech IPO to open on Aug 4; price band set at Rs 448-460/share

Windlas Biotech, manufacturer of pharmaceutical formulations, on Thursday said it has fixed a price band of Rs 448-460 a share for its initial share-sale. The three-day initial public offer (IPO) will open on August 4 and conclude on August 6, the company announced in a virtual press conference. The IPO comprises fresh issuance of equity shares worth Rs 165 crore and and an offer for sale of up to 5,142,067 equity shares. As a part of the OFS, Vimla Windlass will offload 11.36 lakh equity shares, and investor Tano India Private Equity Fund II will sell 40,06,067 equity shares. At the upper end of the price band, the initial share-sale will fetch Rs 401.53 crore. The proceeds from the IPO will be utilised for purchasing of equipment required for capacity expansion of the facility at Dehradun Plant -IV and addition of injectables dosage capability at the facility at Dehradun Plant-II. It will also be used for funding incremental working capital requirements, repayment/ prepayment o

Pharma PLI scheme has export generation potential of Rs 1.96 tn: Mandaviya

PLI for pharmaceutical products has export generation potential of Rs 1,96,000 crore over a period of six years, Parliament was informed on Tuesday.

Sanofi India reports second quarter net profit at Rs 178.3 crore

Revenue from operations of the company stood at Rs 789.1 crore for the quarter under consideration

Dr Reddy's slips over 10% post June quarter results, anonymous complaint

Gross profit margin decreased by 380 bps over the previous year and 150 bps sequentially, majorly on account of price erosion and increase in inventory provisions related to few products

Alembic Pharma dips 8% on disappointing June quarter results

Ebitda (earnings before interest, taxes, depreciation, and amortization) margins declined 1258 basis points (bps) YoY to 17.8 per cent, due to higher other expenditure

Caplin Point jumps 19%, hits record high; stock soars 37% in seven days

A combined 5.8 million equity shares, representing 7.6 per cent of the total equity of Caplin Point Laboratories, had changed hands on NSE and BSE till 12:56 pm

Indian pharma industry to touch $130 bn by 2030: Dr Reddy's chairman

The Indian pharmaceutical industry is expected to grow almost by three times to about 130 billion US dollars by 2030

Glenmark Life Sciences to invest Rs 600 cr to double capacity in four years

Glenmark Life Sciences is the arm of drug major Glenmark Pharmaceuticals.

Gland Pharma rallies 8% on strong revenue growth in June quarter

Gland Pharma said the growth in revenue was contributed from a mix of launch of new products and volume growth in existing products

Gland Pharma Q1 consolidated net profit up 12% to Rs 350.7 crore

Drug firm Gland Pharma on Wednesday reported an 11.83 percent increase in its consolidated net profit to Rs 350.7 crore for the quarter ended June 30, 2021, on account of robust sales in all markets.

Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex

IT, pharma, textile, auto ancillary sectors stand to gain from a weak rupee

The textiles sector saw a recovery in Q4FY21 and a weaker rupee could make it more competitive, and boost exports

Mankind Pharma inks distribution pact with BDR Pharma for Covid drug

Delhi-based Mankind Pharma operates in 34 overseas destinations.

GSK's drugs arm to get $11 billion windfall from consumer spin-off

Investors have been waiting for details of the separation

Laurus Labs gains 2% on robust growth outlook, zooms 70% so far in FY22

The company is looking to build new capacities and facilities that would propel its growth in the coming years

Laurus Labs trades higher for 8th straight day, soars 73% in 3 months

Shares of Laurus Labs continued their upward journey to hit a new high of Rs 599 on the BSE in intra-day trade on Tuesday

Sun Pharma, Ferring Pharma ink pact to introduce obstetric drug in India

The drug is indicated for the prevention of excessive bleeding in women after vaginal or caesarean childbirth

Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg

The medicines are a therapeutic equivalent of Banzel®

Divi's Labs gains 3%, hits new high on strong March quarter results

The board has recommended a dividend of Rs 20 (i.e. 1,000 per cent) per equity share of face value Rs 2 each for the financial year 2020-21